This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://www.jnj.com/media-center/press-releases/johnson-johnson-receives-fda-approval-for-inlexzotm-gemcitabine-intravesical-system